{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:36:20Z","timestamp":1790246180832,"version":"4.1.0"},"reference-count":81,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2014.00186","type":"journal-article","created":{"date-parts":[[2014,7,14]],"date-time":"2014-07-14T12:18:43Z","timestamp":1405340323000},"source":"Crossref","is-referenced-by-count":15,"title":["Infections Caused by Acinetobacter baumannii in Recipients of Hematopoietic Stem Cell Transplantation"],"prefix":"10.3389","volume":"4","author":[{"given":"Khalid Ahmed","family":"Al-Anazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma M.","family":"Al-Jasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2014,7,14]]},"reference":[{"issue":"3","key":"B1","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1128\/CMR.00058-07","article-title":"Acinetobacter baumannii: emergence of a successful pathogen","volume":"21","author":"Peleg","year":"2008","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"B2","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1309\/LM90IJNDDDWRI3RE","article-title":"A review of Acinetobacter baumannii as a highly successful pathogen in times of war","volume":"41","author":"Camp","year":"2010","journal-title":"Lab Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"646195","DOI":"10.1155\/2012\/646195","article-title":"Acinetobacter baumannii septicemia in a recipient of an allogeneic hematopoietic stem cell transplantation","volume":"2012","author":"Al-Anazi","year":"2012","journal-title":"Case Rep Transplant"},{"key":"B4","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1086\/500202","article-title":"The epidemiology and control of Acinetobacter baumannii in health care facilities","volume":"42","author":"Fournier","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"10","key":"B5","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.1128\/AAC.01464-06","article-title":"Global challenge of multidrug-resistant Acinetobacter baumannii","volume":"51","author":"Perez","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"B6","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1517\/14656561003596350","article-title":"Treatment of Acinetobacter infections","volume":"11","author":"Michalopoulos","year":"2010","journal-title":"Expert Opin Pharmacother"},{"issue":"8","key":"B7","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1128\/AAC.00663-12","article-title":"Impact of antibiotic MIC on infection outcome in patients with susceptible Gram-negative bacteria: a systematic review and meta-analysis","volume":"56","author":"Falagas","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"B8","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1345\/aph.1D592","article-title":"Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians","volume":"38","author":"Jain","year":"2004","journal-title":"Ann Pharmacother"},{"issue":"3","key":"B9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1046\/j.1469-0691.2002.00415.x","article-title":"Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem","volume":"8","author":"Levin","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"B10","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1182\/asheducation-2013.1.428","article-title":"Multidrug resistant bacteria: what is the threat?","volume":"2013","author":"Bassetti","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"3","key":"B11","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1128\/AAC.01402-10","article-title":"Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease","volume":"55","author":"Cai","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1093\/jac\/dkr419","article-title":"Efficacy and safety of tigecycline: a systematic review and meta-analysis","volume":"66","author":"Yahav","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"B13","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1086\/526775","article-title":"Clinical and microbiological outcomes of serious infections with multidrug-resistant Gram-negative organisms treated with tigecycline","volume":"46","author":"Anthony","year":"2008","journal-title":"Clin Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/jac\/dkn165","article-title":"Tigecycline for the treatment of multidrug-resistant (including carbapanem-resistant) Acinetobacter infections: a review of the scientific evidence","volume":"62","author":"Karageorgopoulos","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1086\/588051","article-title":"Tigecyline for Acinetobacter baumannii infection: other considerations","volume":"46","author":"Curcio","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"3","key":"B16","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1128\/AAC.01097-08","article-title":"In vitro activities of tigecycline, monocycline and colistin-tigecycline combination against multi-and Pandrug-resistant clinical isolates of Acinetobacter baumannii group","volume":"53","author":"Arroyo","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/jac\/dks084","article-title":"Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies","volume":"67","author":"Cai","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"B18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3346\/jkms.2011.26.3.325","article-title":"The outcomes of using colistin for treating multidrug resistant Acinetobacter species bloodstream infections","volume":"26","author":"Lim","year":"2011","journal-title":"J Korean Med Sci"},{"issue":"6","key":"B19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1469-0691.2008.02126.x","article-title":"Antimicrobial resistance in Europe and its potential impact on empirical therapy","volume":"14","author":"Rossolini","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 2","key":"B20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1086\/320183","article-title":"Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY antimicrobial surveillance program (1997-1999)","volume":"32","author":"Gales","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"3","key":"B21","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/cid\/ciq154","article-title":"Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with Acinetobacter bacteremia","volume":"52","author":"Chuang","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"11","key":"B22","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1128\/AAC.00570-08","article-title":"Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania","volume":"52","author":"Adams-Haduch","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"B23","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1128\/JCM.02373-10","article-title":"Phenotypic and molecular characterization of Acinetobacter clinical isolates obtained from inmates of California correctional facilities","volume":"49","author":"Golanbar","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"5","key":"B24","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3343\/kjlm.2010.30.5.498","article-title":"Genetic basis of multidrug-resistant Acinetobacter baumannii clinical isolates from three University hospitals in Chungcheong Province, Korea","volume":"30","author":"Koo","year":"2010","journal-title":"Korean J Lab Med"},{"issue":"9","key":"B25","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1128\/AAC.00057-10","article-title":"Genomewide anlaysis of divergence of antibiotic resistance determinants in closely related isolates of Acinetobacter baumannii","volume":"54","author":"Adams","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"B26","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/iub.532","article-title":"Genetic basis of antibiotic resistance in pathogenic Acinetobacter species","volume":"63","author":"Poirel","year":"2011","journal-title":"IUBMB Life"},{"key":"B27","first-page":"495","article-title":"Molecular techniques for detection and control of nosocomial infections caused by Acinetobacter baumannii","volume-title":"Science Against Microbial Pathogens: Communicating Current Research and Technological Advances","author":"Sevillano","year":"2011"},{"key":"B28","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/1471-2334-10-196","article-title":"Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital","volume":"10","author":"Dent","year":"2010","journal-title":"BMC Infect Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/1471-2334-10-228","article-title":"Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit","volume":"10","author":"Jung","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"11","key":"B30","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1128\/JCM.01208-10","article-title":"Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a single institution over a 10-year period","volume":"48","author":"Runnegar","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"7","key":"B31","doi-asserted-by":"publisher","first-page":"e69464","DOI":"10.1371\/journal.pone.0069646","article-title":"Toward repurposing ciclopirox as an antibiotic against drug-resistant Acinetobacter baumannii, Escherichia coli and Klebsiella pneumoniae","volume":"8","author":"Carlson-Banning","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"B32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.tim.2012.12.002","article-title":"Emerging therapies for multidrug-resistant Acinetobacter baumannii","volume":"21","author":"Garcia-Quintanilla","year":"2013","journal-title":"Trends Microbiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/jac\/dkr013","article-title":"In vivo and in vitro activity of the siderophore monosulfactam BAL 30072 against Acinetobacter baumannii","volume":"66","author":"Russo","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"B34","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1128\/JCM.42.4.1759-1763.2004","article-title":"Dissemination of a clone of unusual phenotype of pandrug-resistant Acinetobacter baumannii at a University hospital in Taiwan","volume":"42","author":"Kuo","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"8","key":"B35","doi-asserted-by":"publisher","first-page":"4544","DOI":"10.1128\/AAC.00880-12","article-title":"Variation of AbaR4-type resistance islands in Acinetobacter baumannii isolates from South Korea","volume":"56","author":"Kim","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"B36","doi-asserted-by":"publisher","first-page":"5239","DOI":"10.1128\/AAC.00633-13","article-title":"Spread of carbapenem-resistant Acinetobacter baumannii global clone 2 in Asia and AbaR-type resistant islands","volume":"57","author":"Kim","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1093\/jac\/dkq191","article-title":"Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination","volume":"65","author":"Perez","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1177\/0300060513496172","article-title":"In vitro synergistic activity of colistin with tigecycline or \u00ce\u00b2-lactam antibiotic\/\u00ce\u00b2-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii","volume":"41","author":"Karaoglan","year":"2013","journal-title":"J Int Med Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1086\/591134","article-title":"A multifaceted intervention to reduce pandrug-resistant Acinetobacter baumannii colonization and infection in 3 intensive care units in a Thai tertiary care center: 3-year study","volume":"47","author":"Apisarnthanarak","year":"2008","journal-title":"Clin Infect Dis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"B41","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3201\/eid0808.020014","article-title":"Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a University hospital, Taiwan","volume":"8","author":"Hseuh","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1086\/528867","article-title":"Pandrug resistance (PDR), extensive drug resistance (XDR) and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology","volume":"46","author":"Falagas","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"B43","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1086\/504486","article-title":"Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species","volume":"43","author":"Rahal","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"9","key":"B44","doi-asserted-by":"publisher","first-page":"856","DOI":"10.5897\/AJMR2013.6477","article-title":"Synergic bactericidal activity of novel antibiotic combinations against extreme drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii","volume":"8","author":"Aboulmagd","year":"2014","journal-title":"Afr J Microbiol Res"},{"issue":"3","key":"B45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/00365540510026869","article-title":"Treatment of pan-drug resistant Acinetobacter baumannii","volume":"37","author":"Lee","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1086\/322584","article-title":"Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study","volume":"33","author":"Garcia-Garmendia","year":"2001","journal-title":"Clin Infect Dis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/clinids\/22.6.1026","article-title":"Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings and prognostic features","volume":"22","author":"Cisneros","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"11","key":"B48","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1046\/j.1469-0691.2002.00487.x","article-title":"Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment","volume":"8","author":"Cisneros","year":"2002","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"B49","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S0213-005X(03)72930-9","article-title":"Acinetobacter baumannii bacteremia: clinical and prognostic features","volume":"21","author":"Rodriguez-Bano","year":"2003","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"B50","first-page":"127","article-title":"Predictors of mortality in Acinetobacter baumannii bacteremia","volume":"38","author":"Chen","year":"2005","journal-title":"J Microbiol Immunol Infect"},{"key":"B51","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00134-003-1648-8","article-title":"Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study","volume":"29","author":"Blot","year":"2003","journal-title":"Intensive Care Med"},{"issue":"3","key":"B52","first-page":"693","article-title":"Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand","volume":"42","author":"Anunnastsiri","year":"2011","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"2","key":"B53","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3109\/00365548.2013.857042","article-title":"Incidence and risk factors for carbapenem and multidrug-resistant Acinetobacter baumannii bacteremia in hematopoietic stem cell transplantation recipients","volume":"46","author":"Kim","year":"2014","journal-title":"Scand J Infect Dis"},{"issue":"3","key":"B54","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.tim.2012.12.002","article-title":"Emerging therapies for multidrug resistant Acinetobacter baumannii","volume":"21","author":"Garcia-Quintanilla","year":"2013","journal-title":"Trends Microbiol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e46537","DOI":"10.1371\/journal.pone.0046537","article-title":"Isolation and characterization of \u00cf\u2020km18p, a novel lytic phage with therapeutic potential against extensively drug resistant Acinetobacter baumannii","volume":"10","author":"Shen","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"B56","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1128\/AAC.05870-11","article-title":"In vitro activity of telavancin in combination with colistin versus Gram-negative bacterial pathogens","volume":"56","author":"Hornsey","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"B57","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1086\/657139","article-title":"Use of vaporized hydrogen peroxide decontamination during an outbreak of multidrug-resistant Acinetobacter baumannii infection of a long-term acute care hospital","volume":"31","author":"Ray","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"B58","first-page":"9","article-title":"A review of multi drug-resistant Acinetobacter baumannii","volume":"3","author":"Gandham","year":"2014","journal-title":"Int J Curr Microbiol Appl Sci"},{"key":"B59","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/jac\/dkr408","article-title":"In vitro antimicrobial studies of silver carbene complexes: activity of free and nanoparticle carbene formulations against clinical isolates of pathogenic bacteria","volume":"67","author":"Leid","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"B60","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1471-2164-15-36","article-title":"Antibac TR: dynamic antibacterial-drug-target ranking integrating comparative genomics, structural analysis and experimental annotation","volume":"15","author":"Panjkovich","year":"2014","journal-title":"BMC Genomics"},{"key":"B61","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1086\/317943","article-title":"Current status of granulocyte (neutrophil) transfusion therapy for infectious diseases","volume":"183","author":"Hubel","year":"2001","journal-title":"J Infect Dis"},{"issue":"12","key":"B62","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.3324\/haematol.2009.013680","article-title":"Granulocyte transfusion therapy: randomization after all?","volume":"94","author":"Drewniak","year":"2009","journal-title":"Haematologica"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1002\/cncr.20710","article-title":"Impact of high-dose granulocyte transfusions in patients with cancer with candidemia","volume":"101","author":"Safdar","year":"2004","journal-title":"Cancer"},{"issue":"1","key":"B64","doi-asserted-by":"publisher","first-page":"CD005341","DOI":"10.1002\/14651858.CD005341.pub2","article-title":"Granulocyte transfusions for preventing infections in patients with neutropenia or neutrophil dysfunction","author":"Massey","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"B65","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/sj.leu.2402007","article-title":"Clinical efficacy of granulocyte transfusion therapy in patients with neutropenia-related infections","volume":"15","author":"Lee","year":"2001","journal-title":"Leukemia"},{"key":"B66","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1365-2141.2004.05221.x","article-title":"The role of granulocyte transfusions in neutropenic patients","volume":"127","author":"Bishton","year":"2004","journal-title":"Br J Haematol"},{"issue":"12","key":"B67","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.3324\/haematol.2009.010231","article-title":"Granulocyte transfusions in severe aplastic anemia: an eleven-year experience","volume":"94","author":"Quillen","year":"2009","journal-title":"Haematologica"},{"issue":"2","key":"B68","doi-asserted-by":"publisher","first-page":"e88148","DOI":"10.1371\/journal.pone.0088148","article-title":"Granulocyte transfusion combined with granulocyte colony stimulating factor in severe infection patients with severe aplastic anemia: a single center experience from China","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"B69","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1182\/blood-2011-10-345751","article-title":"Blood consult: granulocyte transfusions to treat invasive aspergillosis in a patient with severe aplastic anemia awaiting mismatched hematopoietic progenitor cell transplantation","volume":"119","author":"O\u00e2\u20ac\u2122Donghaile","year":"2012","journal-title":"Blood"},{"key":"B70","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/sj.bmt.1705233","article-title":"Pre-emptive granulocyte transfusions enable allogeneic hematopoietic stem cell transplantation in pediatric patients with chronic infections","volume":"37","author":"Sharon","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"B71","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/00062752-200105000-00006","article-title":"Granulocyte transfusion therapy: update on potential clinical applications","volume":"8","author":"Hubel","year":"2001","journal-title":"Curr Opin Hematol"},{"key":"B72","first-page":"1","volume-title":"Granulocyte Transfusions","author":"Goldfinger","year":"2014"},{"issue":"3","key":"B73","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/tid.12013","article-title":"Granulocyte transfusion in pediatric hemato-oncology and hematopoietic stem cell transplantation","volume":"12","author":"Ball","year":"2007","journal-title":"Rep Pract Oncol Radiother"},{"key":"B74","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1046\/j.1365-2141.1999.01619.x","article-title":"Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients","volume":"106","author":"Peters","year":"1999","journal-title":"Br J Haematol"},{"issue":"1","key":"B75","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1182\/blood.V95.11.3302","article-title":"Phase I\/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation","volume":"95","author":"Price","year":"2000","journal-title":"Blood"},{"issue":"3","key":"B76","doi-asserted-by":"publisher","first-page":"CD005339","DOI":"10.1002\/14651858.CD005339","article-title":"Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction","author":"Stanworth","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"B77","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1128\/JCM.41.10.4892-4893.2003","article-title":"Serial granulocyte transfusions as a treatment for sepsis due to multidrug resistant Pseudomonas aeruginosa in a neutropenic patient","volume":"41","author":"Lin","year":"2003","journal-title":"J Clin Microbiol"},{"key":"B78","first-page":"71","article-title":"Combined treatment with amphotericin-B and granulocyte transfusion from G-CSF-stimulated donors in an aplastic patient with invasive aspergillosis undergoing bone marrow transplantation","volume":"82","author":"Catalano","year":"1997","journal-title":"Haematologica"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/sj.bmt.1702651","article-title":"Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation","volume":"26","author":"Bielori","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"17","key":"B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2013.00017","article-title":"Immunotherapy of invasive fungal infection in hematopoietic stem cell transplant recipients","volume":"3","author":"Lehmbecher","year":"2013","journal-title":"Front Oncol"},{"issue":"8","key":"B81","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/cid\/cir492","article-title":"Infections in patients with hematologic neoplasms and hematopoietic stem cell transplantation: neutropenia, humoral, and splenic defects","volume":"53","author":"Safdar","year":"2011","journal-title":"Clin Infect Dis"}],"container-title":["Frontiers in Oncology"],"original-title":[],"deposited":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T07:13:20Z","timestamp":1598080400000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fonc.2014.00186\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,14]]},"references-count":81,"URL":"https:\/\/doi.org\/10.3389\/fonc.2014.00186","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,14]]}}}